|
May 15
|
Voyager Demonstrates ALPL Receptor-Mediated Blood-Brain Barrier Transport of Novel AAV Capsids in Molecular Therapy Publication
|
|
Apr 21
|
Voyager Therapeutics Inc (VYGR) Q4 2024 Earnings Call Highlights: Strong Financial Position and ...
|
|
Mar 12
|
Q4 2024 Voyager Therapeutics Inc Earnings Call
|
|
Mar 11
|
Voyager Therapeutics (VYGR) Reports Q4 Loss, Misses Revenue Estimates
|
|
Mar 11
|
Voyager Therapeutics: Q4 Earnings Snapshot
|
|
Mar 11
|
Voyager Reports Fourth Quarter and Full Year 2024 Financial and Operating Results
|
|
Dec 29
|
Voyager Therapeutics, Inc. (VYGR): Is This Gene Therapy Stock a Good Buy Right Now?
|
|
Nov 14
|
Declining Stock and Decent Financials: Is The Market Wrong About Voyager Therapeutics, Inc. (NASDAQ:VYGR)?
|
|
Nov 13
|
Q3 2024 Voyager Therapeutics Inc Earnings Call
|
|
Nov 13
|
Voyager Therapeutics Inc (VYGR) Q3 2024 Earnings Call Highlights: Strong Cash Position and ...
|
|
Nov 12
|
Voyager Therapeutics (VYGR) Reports Q3 Loss, Tops Revenue Estimates
|
|
Nov 12
|
Voyager Therapeutics: Q3 Earnings Snapshot
|
|
Nov 12
|
Voyager Reports Third Quarter 2024 Financial and Operating Results
|
|
Oct 7
|
Strength Seen in Voyager Therapeutics (VYGR): Can Its 17.5% Jump Turn into More Strength?
|
|
May 16
|
Voyager Therapeutics Announces First Participants Dosed in Single Ascending Dose Trial of VY-TAU01 for the Treatment of Alzheimer’s Disease
|
|
May 14
|
Q1 2024 Voyager Therapeutics Inc Earnings Call
|
|
May 14
|
Voyager Therapeutics Inc (VYGR) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
|
|
May 13
|
Voyager Therapeutics (VYGR) Reports Q1 Loss, Tops Revenue Estimates
|
|
May 13
|
Voyager Therapeutics Reports First Quarter 2024 Financial and Operating Results
|
|
May 8
|
Voyager Therapeutics Presents Data for Second-Generation, TRACER™-Generated Capsids and CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting
|